Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Lyrinel XL
Active Ingredient: Oxybutynin hydrochloride 10mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Corporation, Mountain View, California, United States of America
Product: Lyrinel XL
Active Ingredient: Oxybutynin hydrochloride 15mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Corporation, Mountain View, California, United States of America
Product: Lyrinel XL
Active Ingredient: Oxybutynin hydrochloride 5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer: Alza Corporation, Mountain View, California, United States of America
Product: Metronidazole
Active Ingredient: Metronidazole 5mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Claris Life Sciences Limited, Chacharwadi-Vasana, Ahmedabad, India
Product: Optrex Allergy Eyes
Active Ingredient: Sodium cromoglycate 2%w/v
Dosage Form: Eye drops, solution
New Zealand Sponsor: Reckitt Benckiser (New Zealand) Limited
Manufacturer: Tubilux Pharma SpA, Pomezia, Rome, Italy
Product: Sevoflurane
Active Ingredient: Sevoflurane 100%
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Corporation of Puerto Rico, Guayama, Puerto Rico
Dated this 23rd day of March 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).